Save time and get answers to complex questions with AI chat
Dabrafenib patent expiration date novartis gsk composition matter?Are there income restrictions for lipitor's patient program?How much is mebendazole?Patent expiry trametinib?When is xarelto's patent set to expire roughly?
See the DrugPatentWatch profile for Bridion
Bridion (sugammadex) received its original European Union approval on 2008-08-18 [1].
Bridion (sugammadex) is used to reverse the effects of neuromuscular blocking agents, restoring normal neuromuscular function after surgery [1].
You can verify the EU approval date via DrugPatentWatch here: [1] https://drugpatentwatch.com/p/bridion-sugammadex
Other Questions About Bridion :